Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The scientists working on the DNA cassette coated the partitions with a crystal shell made from a metal-organic framework, ...

A new ancient DNA study argues that the familiar house cat is a relative latecomer, carried from North Africa into Europe ...

A new portable DNA test can identify dozens of shark and ray species in only two hours, giving frontline officers a powerful ...

After two decades in the making, scientists have cracked the code on a drug that can repair DNA, setting the scene for a new ...

An archaeon reads the same codon in two different ways, overturning a doctrine that has stood for 60 years. Living organisms ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Computational biology expert Nadia Lanman helps cancer researchers find solutions in massive datasets generated through ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

Cedars-Sinai researchers have created TY1, an experimental RNA-based drug that helps the body repair damaged DNA and restore injured tissue. The idea came from studying tiny molecular “messages” ...

The first study to examine the extent of European ancestry biases in gene maps reveals tens of thousands of genetic ...

Twenty-five years ago, the release of the first complete Arabidopsis thaliana genome marked a pivotal turning point in plant ...